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CRYPTOCOCCAL MENINGITIS IN HIV NEGATIVE PREGNANT WOMEN:  
CASE REPORT AND REVIEW OF LITERATURE
Maria Laura Botelho COSTA, João Paulo Dias de SOUZA, Antônio Francisco de OLIVEIRA NETO  & João Luiz PINTO E SILVA
SUMMARY
Introduction: Cryptococcosis has become an important entity due to the epidemic of AIDS and therefore it is a significant 
opportunistic infection. However, there are case reports of cryptococcal meningitis in immune competent pregnant women. Since 
pregnancy is considered a period of relative immunosuppression, which likely prevents fetal rejection, this could explain the 
occurrence of opportunistic infections. Objective: To report a case of cryptococcosis, and review all cases involving pregnancy and 
neurocryptococcal infection in immune competent pregnant patients. Methods: Case report and systematic review of the literature using 
the MEDLINE and SciELO databases. Discussion: A total of 27 patients were analyzed from 19 studies. The mean age at diagnosis 
was 26.4 years. There were six patients in their first trimester of pregnancy, 10 in the second, eight in the third and three post-partum. 
The most prevalent symptoms were headache (85.2%), altered vision (44.4%), altered mental status (44.4%), nausea (40.7%) and 
fever (33.3%). There were nine deaths (33.3%). Most of the patients received intravenous amphotericin B as treatment (77.8%). The 
majority (66.6%) of the patients accomplished a term delivery with healthy infants. Conclusion: Cryptococcal meningitis should be 
considered during pregnancy in cases of unexplained headache, altered vision, altered mental status, nausea and fever. Patients with 
a confirmed diagnosis should be admitted and treated with amphotericin B. 
KEYWORDS: Cryptococcal meningitis; Cryptococcosis; Pregnancy; Antifungal therapy.
INTRODUCTION 
Cryptococcosis has been recognized as a clinical entity for over 110 
years, since the discovery of Cryptococcus neoformans by SANFELICE25. 
Its occurrence was historically characterized as sporadic and generally 
associated with diseases that lead to cellular immune deficiency, such as 
leukemia, Hodgkin’s disease, diabetes and systemic lupus16. However, due 
to the epidemic nature of acquired immunodeficiency syndrome (AIDS) 
cryptococcosis has become a major opportunistic infection accounting 
for morbidity and mortality in AIDS patients. 
Two species within the genus Cryptococcus: C. neoformans 
(serotypes A, D, and hybrid AD) and C. gattii (serotypes B and C) are 
recognized to cause life-threatening disease16. The infection caused by 
Cryptococcus neoformans species complex has universal distribution, 
occurs in immune compromised individuals, and in urban environments 
rich in bird’s feces. The infection caused by Cryptococcus gatti is 
considered prevalent in tropical and subtropical regions, affecting immune 
competent individuals from the rural areas, where the fungus is found in 
trees, particularly Eucalyptus spp.18.
In Brazil, cryptococcosis caused by C. neoformans occurs in all 
regions, however, C. gattii behaves as a primary pathogen and infects 
mostly native immunocompetent hosts (specially children and young 
people) in the North and Northeast (NE) regions of the country. The 
Southern macro region shows sporadic infections by this agent30.
Cryptococcus is a yeast fungus that most frequently infects the central 
nervous system (CNS) through hematogenous spread after inhalation 
into the lungs. Headaches and mild temperature elevation appear at the 
onset of CNS involvement, but other symptoms similar to those of an 
intracranial lesion or meningitis may arise subsequently26. The diagnosis 
of cryptococcal meningitis is often difficult. The headache, in the frontal 
and temporal regions, is intermittent at onset, but becomes continuous and 
progressively severe. Visual disturbances like diplopia and photophobia 
are also early symptoms. Other ocular disorders include neuroretinitis, 
retinal hemorrhages, strabismus, nystagmus, anisocoria, ptosis, retinal 
exudates, optic nerve atrophy and ophthalmoplegia. Papilledema is 
present in half of active cases, due to increased spinal fluid pressure17.
The initial site of infection in the lungs usually heals by 
encapsulation, leaving no recognizable tissue damage or just a nodule 
called cryptococcoma. However, a pneumonic form of cryptococcosis 
can occur and symptoms may include cough, chest pain, fever, weight 
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loss and sputum production. Other forms of cryptococcal disease, such 
as cutaneous, visceral or bone disease are rare and prompt evaluation of 
cerebrospinal fluid even if no meningeal signs are present26.
Lumbar puncture in infected individuals reveals a spinal fluid clear, 
rarely turbid or xanthochromic in its appearance, depending on the stage 
or severity of the disease. Elevated pressures (up to 700 mmH2O) and 
protein counts as well as decreased glucose are other spinal findings17. 
The fungus can be visualized in cerebrospinal fluid with India ink mounts, 
where typical halo cells are seen8.
The aspect of the pathologic lesion is either mucoid or granulomatous, 
depending on the degree of cellular reaction. The fungus can be visualized 
in tissue by use of mucicarmine stain8.
Pregnancy represents a vulnerable time for both mother and fetus, and 
is considered a period of relative immune suppression. During pregnancy, 
the mother’s immunological status is down regulated in part to prevent 
fetal rejection due to paternally-derived histocompatibility antigens3.
There is still no clear evidence that pregnancy is a predisposing factor 
for cryptococcosis, however, the alteration of maternal T-cell activity, 
natural killer cells, polymorphonuclear leukocytes, macrophages, and 
specific antibodies may play an important role in the development of 
this disease10. 
During pregnancy, the trophoblast does not express the classical 
major histocompatibility complex (MHC) class Ia or II molecules that are 
needed to present antigenic peptides to cytotoxic and T-helper (Th) cells, 
respectively. Instead, human leukocyte antigen (HLA)-G, a nonclassical 
MHC Ib molecule, is expressed. HLA-G may be a ligand for the natural 
killer cell receptor, therefore protecting the fetus from natural killer 
cell damage; activating suppressive CD8+ T cells, and influencing the 
organism’s response towards an infection13. 
Another important aspect to consider during pregnancy is the use of 
antifungal agents and the possible toxicities to the fetus. Treatment with 
amphotericin B for central nervous system (CNS) cryptococcosis during 
pregnancy has been suggested since 1958, and is usually considered 
the first therapeutic option with reported favorable maternal and fetal 
outcomes. This agent has a Food and Drug Administration (FDA) 
category B rating for use in pregnancy, with manageable toxicities of 
anemia, hypokalemia, and renal dysfunction for both mother and fetus10. 
No data is available to determine the optimal duration of antifungal 
therapy for cryptococcosis during pregnancy. However, nonpregnant 
patients without AIDS are treated with amphotericin B with or without 
flucytosine for 4-6 weeks based on clinical trial data2,9. After delivery, 
a change from amphotericin B to fluconazole has been postulated, to 
avoid amphotericin B’s toxicity to the post-partum patient10. The use of 
antifungal agents during lactation is still unsettled and not recommended, 
with limited studies to support its safety.
Cryptococcosis in pregnancy, specially the neurologic presentation, 
represents a challenging clinical entity, as regards to the differential 
diagnosis it imposes and the remaining knowledge gaps on treatment 
and patient safety aspects. We faced one of these cases and to better 
understand cryptococcosis in pregnancy, we systematically reviewed all 
published cases involving pregnancy and neurocryptococcal infection in 
apparently immunocompetent patients without human immunodeficiency 
virus (HIV) infection. We were interested in identifying the symptoms 
present at the time of diagnosis, the maternal-fetal morbidity and 
mortality, and the type of treatment. In addition, we also report the case 
that motivated this systematic review.
METHODS
Search methods for identification of studies: The search of reports 
of cryptococcal meningitis cases diagnosed during pregnancy was 
carried out in the scientific literature covering a wide range of journals 
through MEDLINE and SciELO. These databases were investigated 
using the following search strategy: (“cryptococcal” or “Cryptococcus” 
or “cryptococcosis” or “neurocryptococcosis” or “torulosis”) and 
(“pregnancy” or “maternal” or “gestational”).
All reports of mycology proven cases of cryptococcal meningitis 
diagnosed during pregnancy were analyzed. 
RESULTS
Case Report: A 37 year-old white Brazilian woman, 14 weeks 
pregnant, with a background of arterial hypertension, using methyldopa, 
was admitted due to altered mental status and dyslalia. The symptoms 
progressed with right-sided paresis, nausea, vomiting and divergent 
strabismus. Following the initial clinical assessment, computerized 
tomography scan and magnetic resonance imaging of her brain were 
obtained, with normal findings. The patient was subsequently transferred 
to the intensive care unit of the State University of Campinas Women’s 
hospital (CAISM/UNICAMP), for observation and further examination. 
Hepatic and renal functions, electrolytes, and serology for hepatitis, 
syphilis and HIV were negative. Blood cultures were also negative. A 
lumbar puncture was performed and revealed an opening pressure of 
850 mm H20, suggesting increased intracranial pressure (ICP). The 
cerebrospinal fluid analysis (CSF analysis) revealed a pleocytosis [red 
blood cells - 210 mm³ and leukocytes 272 mm³ (neutrophils 70%; 
lymphocytes 27%; eosinophils 2%; monocytes 1%)], a reduced glucose 
level (16 mg/dL), and an elevated protein level (95 mg/dL). The diagnosis 
of cryptococcal meningitis was confirmed by the identification of the 
Cryptococcus neoformans isolated in CSF culture (53 cells/mm3). 
Treatment with intravenous amphotericin B (monotherapy) was given 
with a total dose of 1500 mg (daily dosage of 50 mg during 30 days) and 
lumbar punctures were performed daily to monitor intracranial pressure, 
with liquoric drainage (10-20 mL) whenever a pressure over 250 mmHg 
was noted. The patient responded to therapy with regression of symptoms 
and within five days of treatment, the ICP kept lower than 180 mmH2O. 
During this recovery period, laboratory tests showed maintained renal and 
hepatic functions but low levels of potassium that required intravenous 
repletion. Thirty days after admission, the patient was discharged to 
complete treatment with oral fluconazol (750 mg/day). The patient was 
examined every two weeks at the hospital’s specialized prenatal care 
unit with adequate fetal growth. She required a beta-blocker for blood 
pressure control and daily oral solution of potassium for repletion. After 
sixteen weeks of oral fluconazol, a new lumbar puncture was performed 
and culture was negative for Cryptococcus spp. The medication was then 
gradually discontinued. 
COSTA, M.L.B.; SOUZA, J.P.D.; OLIVEIRA NETO, A.F. & PINTO E SILVA, J.L. - Cryptococcal meningitis in HIV negative pregnant women: case report and review of literature. Rev. 
Inst. Med. trop. S. Paulo, 51(5): 289-294, 2009.
291
At 38 weeks of pregnancy, the patient was hospitalized in labor. 
Hours later, an emergency Cesarean-section was performed due to fetal 
distress. A healthy newborn was delivered. The newborn was adequate 
for gestational age, weighing 3095g with an Apgar score of 9/10 .
REVIEW OF LITERATURE
The electronic search resulted in the identification of 26 mycology 
proven cases of cryptococcal meningitis diagnosed during pregnancy 
in HIV negative women, from which 23 have already been reported in 
a review by ELY et al. (1998). Characteristics of the 26 cases and the 
present case are listed in Table 1. 
The mean age of patients at diagnosis was 26.4 years-old. There 
were six patients in their first trimester of pregnancy, 10 in the second 
trimester, eight in the third trimester and three in post-partum period. 
The most prevalent symptoms were headache (85.2%) followed by 
altered vision (44.4%), including photophobia, blurred vision, diplopia, 
strabismus and papilledema. Altered mental status accounted for 44.4% 
of the symptoms, including: poor memory, dizziness, neck stiffness, 
somnolence, convulsions and coma. Nausea and vomiting were reported 
in 40.7% of the patients and fever in 33.3%. 
Nine of these 27 patients (33.3%) died (cases 1, 2, 3, 8, 9, 10, 11, 13 
and 26). Eight deaths occurred in reports that preceeded the year 1975. 
5/27 (18.5%) patients that died had no adequate systemic treatment 
for cryptococcosis (cases 1, 8, 10, 11 and 26), and/or only confirmed 
diagnosis after autopsy. 
Most of the patients analyzed (21/27) received intravenous 
amphotericin B as their antifungal therapy (77.8%), with doses ranging 
from 600 to 7200 mg. Five of these 27 cases (18.5%) were treated with 
complementary intrathecal amphotericin B (cases 6,7,12,17,21). Other 
antifungal drugs were described, such as flucytosine (cases 17, 22 and 
24), oral fluconazole (cases 23 and 27) and itraconazole (case 20).
In regards to fetal and maternal outcomes, there were four cases of 
fetal death (14.8%). One of them due to the mother’s request of pregnancy 
termination at 24 weeks (case 18), and one due to miscarriage (3.7%). 
Unfortunately seven cases (25.9%) did not provide information about 
fetal outcomes and another four (14.8%) did not provide any additional 
information other than if a successful pregnancy and delivery occurred. 
Despite the suboptimal information in some reports, it was clear that 
the majority of patients achieved a term or close to term delivery with 
healthy infants lacking overt signs of cryptococcal disease at time of 
birth or during follow-up (cases of up to four years of follow-up). There 
were two women with pre-eclampsia (cases 8 and 24).
DISCUSSION
Cryptococcosis is an important opportunistic disease in patients with 
AIDS or those undergoing immunosuppressive therapy. Cryptococcal 
meningitis is the most frequent clinical presentation. During pregnancy, 
the disease is rare and its course and possible complications have not been 
completely understood. Most studies suggest that the clinical features, 
course and outcome of cryptococcal meningitis are not influenced by 
pregnancy5. 
However,  pregnancy is  considered a t ime of relat ive 
immunosuppression, which could in theory create a predisposition for 
opportunistic fungal infections, such as cryptococcosis10. For this reason, 
the diagnosis of cryptococcosis should be considered and pursued in 
pregnant patients presenting with altered vision, severe headache, altered 
mental status, seizures, nausea and unexplained fever.
Defining a population of pregnant patient at increased risk is a 
difficult task, since the pathological agents, Cryptococcus neoformans 
and Cryptococcus gattii, can be found in both, urban and rural areas, on 
house dust, in decomposed plants and in bird and bat feces22. 
The case reported here and the review of 26 other cases from the 
literature shows impressive positive outcomes in patients correctly 
diagnosed and treated. The best results have been seen after 1975, with 
better intensive care practices and the use of amphotericin B. Fetal 
malformations have not been reported in these cases.
The recommendation for a patient with suggestive symptoms of 
cryptococcosis should include a detailed medical history, physical exam, 
blood, urine, sputum cultures for acid fast bacilli and fungi, lumbar 
puncture, serum cryptococcal antigen and histopathology analysis. 
Once a diagnosis is established, amphotericin B with or without 
flucytosine is recommended. Careful monitoring for toxicities should 
be instituted, with daily renal function, electrolytes and complete 
blood count exams, to manage possible adverse effects such as anemia, 
hypokalemia and renal dysfunction. After delivery, the switch to oral 
fluconazole (400 to 800 mg/day), a class C FDA medication, should be 
considered and breast feeding avoided10.
No data is available to ascertain the optimal duration of antifungal 
therapy for cryptococcosis during pregnancy, but non-pregnant 
immunocompetent women are treated for 4-6 weeks, based on 
controlled trials. A possible management of the disease in pregnancy is 
to individualize treatment and monitor each patient’s clinical response, 
using serial laboratorial and imaging exams10.
There are no documented cases of fetal infection in immunocompetent 
patients with cryptococcosis. Only two cases of placental cryptococcosis 
have been reported, both in severely immunocompromised women, one of 
them with lupus20 and the other with AIDS19. However, none had newborns 
with demonstrable infection. There are three reported cases of possible 
vertical transmission, all of them in mothers co-infected with HIV4. 
CONCLUSION
Cryptococcosis is one the most important fungal infections in Brazil 
with numerous case reports and region particularities. There has been 
an effort to answer doubts and to define a consensus for diagnosis, 
management and treatment of the disease with a guideline published in 
2008 as a technical report28. 
However, cryptococcal meningitis is rarely diagnosed during 
pregnancy, but it should be regarded as a possible entity in cases of 
unexplained headache, altered vision, altered mental status, nausea and 
fever. Pregnant patients with a confirmed diagnosis should be admitted 
and treated with amphotericin B. 
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New studies and case reports are needed to assure the safety and 
effectiveness of treatment with newer antifungal agents. 
RESUMO
Meningite criptocóccica em gestante HIV negativa: 
relato de caso e revisão da literatura
Introdução: Com a epidemia da AIDS, a neurocriptococose 
foi melhor estudada e considerada infecção fúngica oportunista. 
No entanto, há casos descritos de gestantes acometidas, apesar de 
imunocompetentes. A gestação, por si só, pode ser considerada um 
período de imunossupressão, para adaptação materno-fetal, o que 
poderia predispor à instalação de certas infecções. Objetivos: Relato 
de caso de gestante com neurocriptococose e revisão sistemática dos 
casos descritos na literatura desta patologia durante a gestação, em 
pacientes imunocompetentes. Metodologia: Revisão sistemática com 
busca MEDLINE e SciELO. Resultados: Foram analisadas 27 pacientes 
com diagnóstico de neurocriptococse na gestação. A média de idade foi 
26,4 anos. Seis pacientes estavam no primeiro trimestre de gravidez 
ao diagnóstico, 10 no segundo, oito no terceiro e três eram puérperas. 
O sintoma mais prevalente foi cefaléia (85,2%), seguido por alteração 
visual (44,4%), confusão mental (44,4%), náusea (40,7%) e febre (33%). 
Houve nove óbitos maternos (33,3%). Vinte e uma pacientes foram 
tratadas com anfotericina B (77,8%). A maioria dos casos evoluiu com 
gestação a termo, com recém-nascidos saudáveis (66,6%). Conclusões: 
Neurocriptococose deve ser um diagnóstico a se considerar na gestação, 
nos casos de cefaléia, alteração visual, confusão mental, náusea e febre 
persistentes, sendo indicada terapia intensiva e uso de anfotericina B.
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